Hyperthyroidism in Patients with Chronic Lymphocytic Leukemia
Iraqi Journal of Medical Sciences · 08.06.2023 · 21 (1)
DOI: 10.22578/ijms.21.1.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iraqi Journal of Medical Sciences, online erschienen am 08.06.2023. Verfasst von Waleed H. Saeed.
Abstract (Originalsprache)
Background
Chronic lymphocytic leukemia (CLL) is a hematological malignancy characterized by the accumulation of immunologically mature cluster of differentiation (CD) 5+ B-lymphocytes in the blood, bone marrow and lymphatic tissues. Hyperthyroidism can occasionally be caused by non-thyroid cancers infiltrating the thyroid and cause hyperthyroidism.
Objective
To assess the thyroid function of patients with CLL.
Methods
Patients and participant controls are subjected to prevalence tests of thyroid function as thyroid stimulating hormone (TSH), thyroxine (T4) and triiodothyronine (T3). Serum samples were analyzed by specialized kits of immunodiagnostic mini VIDAS Industry system (BioMérieux, France).
Results
Out of 37 males and 17 females CLL patients and 60 volunteer controls (36 males and 24 females), only two male patients at their sixth decade were diagnosed with hyperthyroidism, these patients were classified as Stage (A) to the Binet staging system. The test results were showed as follow: TSH;
Zitieren
APA
Saeed, W. H. (2023). Hyperthyroidism in Patients with Chronic Lymphocytic Leukemia. Iraqi Journal of Medical Sciences, 21(1). https://doi.org/10.22578/ijms.21.1.12
Vancouver
Saeed WH. Hyperthyroidism in Patients with Chronic Lymphocytic Leukemia. Iraqi Journal of Medical Sciences. 2023;21(1). doi:10.22578/ijms.21.1.12
BibTeX
@article{Saeed2023,
author = {Saeed, Waleed H.},
title = {Hyperthyroidism in Patients with Chronic Lymphocytic Leukemia},
journal = {Iraqi Journal of Medical Sciences},
year = {2023},
volume = {21},
number = {1},
doi = {10.22578/ijms.21.1.12}
}
EUVIMED